These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1837744)

  • 1. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study.
    van Schayck CP; Dompeling E; van Herwaarden CL; Folgering H; Verbeek AL; van der Hoogen HJ; van Weel C
    BMJ; 1991 Dec; 303(6815):1426-31. PubMed ID: 1837744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous and on demand use of bronchodilators in patients with non-steroid dependent asthma and chronic bronchitis: four-year follow-up randomized controlled study.
    van Schayck CP; Dompeling E; van Herwaarden CL; Folgering H; Akkermans RP; van den Broek PJ; van Weel C
    Br J Gen Pract; 1995 May; 45(394):239-44. PubMed ID: 7619569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis.
    van Schayck CP; Folgering H; Harbers H; Maas KL; van Weel C
    Thorax; 1991 May; 46(5):355-9. PubMed ID: 1829865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis.
    Lightbody IM; Ingram CG; Legge JS; Johnston RN
    Br J Dis Chest; 1978 Jul; 72(3):181-6. PubMed ID: 151547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis.
    Higgins BG; Powell RM; Cooper S; Tattersfield AE
    Eur Respir J; 1991 Apr; 4(4):415-20. PubMed ID: 1830277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of acute bronchodilator effects of inhaled ipratropium bromide and salbutamol in bronchial asthma.
    Chhabra SK; Pandey KK
    J Asthma; 2002 Aug; 39(5):375-81. PubMed ID: 12214891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials.
    Lanes SF; Garrett JE; Wentworth CE; Fitzgerald JM; Karpel JP
    Chest; 1998 Aug; 114(2):365-72. PubMed ID: 9726716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of higher than standard doses of salbutamol and ipratropium on tiotropium-induced bronchodilation in patients with stable COPD.
    Cazzola M; Santus P; D'Adda A; Pizzolato S; Di Marco F; Centanni S
    Pulm Pharmacol Ther; 2009 Jun; 22(3):177-82. PubMed ID: 19038356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide.
    Thiessen B; Pedersen OF
    Respiration; 1982; 43(4):304-16. PubMed ID: 6213991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilator action of the anticholinergic drug, ipratropium bromide (Sch 1000), as an aerosol in chronic bronchitis and asthma.
    Baigelman W; Chodosh S
    Chest; 1977 Mar; 71(3):324-8. PubMed ID: 138578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.
    Britton J; Hanley SP; Garrett HV; Hadfield JW; Tattersfield AE
    Thorax; 1988 Apr; 43(4):300-5. PubMed ID: 2970125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
    Donohue JF; Wise R; Busse WW; Garfinkel S; Zubek VB; Ghafouri M; Manuel RC; Schlenker-Herceg R; Bleecker ER
    BMC Pulm Med; 2016 Apr; 16(1):65. PubMed ID: 27130202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction.
    Barros MJ; Rees PJ
    Respir Med; 1990 Sep; 84(5):371-5. PubMed ID: 2147295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma.
    Petrie GR; Palmer KN
    Br Med J; 1975 Feb; 1(5955):430-2. PubMed ID: 1090337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis.
    Leitch AG; Hopkin JM; Ellis DA; Merchant S; McHardy GJ
    Thorax; 1978 Dec; 33(6):711-3. PubMed ID: 154748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study.
    Dompeling E; van Schayck CP; van Grunsven PM; van Herwaarden CL; Akkermans R; Molema J; Folgering H; van Weel C
    Ann Intern Med; 1993 May; 118(10):770-8. PubMed ID: 8470851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a single dose of aerosol salbutamol and fenoterol/ipratropium on bronchial asthmatic patients.
    Filiz A; Ekinci E; Dikensoy O; Bulgur D; Oz M
    Del Med J; 1994 Oct; 66(10):549-52. PubMed ID: 7958119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol.
    van Schayck CP; Graafsma SJ; Visch MB; Dompeling E; van Weel C; van Herwaarden CL
    J Allergy Clin Immunol; 1990 Nov; 86(5):793-800. PubMed ID: 1977787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.